NCT02492373View on ClinicalTrials.gov

Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
LentiginesPost Inflammatory Hyperpigmentation
Interventions
DRUG

topical 0.05% Clobetasol propionate ointment

Apply only on the treated area twice a day as mentions

DEVICE

Q switched Nd:YAG laser 532 nm

Treatment of facial lentigines. The energy using depends on the endpoint of immediate whitening of the lesions.

Trial Locations (1)

10700

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT02492373 - Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser | Biotech Hunter | Biotech Hunter